Stocks Featured in Zacks Equity Research Analyst Blog

Strategic Insights -

Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. In the latest Analyst Blog, five stocks were featured, including Skyworks Solutions, Inc., General Motors Corp., Wilmington Trust Corp., Micromet Inc., and Embraer. Despite stellar guidance and ahead-of-expectations Q2 results, shares of Skyworks Solutions are lower in trading. General Motors will temporarily shut 13 assembly plants, affecting 24,000 workers. Wilmington Trust Corp. reported a net income of $21.8 million, beating estimates. Micromet Inc. announced a rapid path to market for its lead drug candidate blinatumomab. The Brazilian government increased credit lines to Argentina, which will finance Aerolineas Argentinas' acquisition of 20 Embraer jets.

Key Takeaways:

  • Skyworks Solutions, Inc. (NASDAQ: SWKS) posted Q2 revenue of $173 million with non-GAAP EPS of $0.12, better than expected.
  • General Motors Corp. (NYSE: GM) will temporarily shut 13 assembly plants, affecting 24,000 workers, due to the current financial crisis.
  • Wilmington Trust Corp. (NYSE: WL) reported Q1 net income of $21.8 million, beating estimates.
  • Micromet Inc. (NASDAQ: MITI) announced a rapid path to market for its lead drug candidate blinatumomab.
  • The Brazilian government increased credit lines to Argentina from $120 million to $1.5 billion, which will finance Aerolineas Argentinas' acquisition of 20 Embraer jets.
  • Embraer (NYSE: ERJ) has been facing a difficult period due to the global crisis reducing demand from airline companies worldwide.
  • Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and sell for the long-term.

Statistics:

  • Skyworks Solutions (NASDAQ: SWKS) posted Q2 revenue of $173 million.
  • General Motors Corp. (NYSE: GM) will temporarily shut 40% of its US assembly facilities.
  • Wilmington Trust Corp. (NYSE: WL) reported Q1 net income of $21.8 million.
  • Micromet Inc. (NASDAQ: MITI) has a lead drug candidate blinatumomab for acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma.
  • The Brazilian government increased credit lines to Argentina from $120 million to $1.5 billion.
  • Embraer (NYSE: ERJ) has 1,150 publicly traded stocks in its universe.

Sources:

  • Zacks Equity Research
  • Zacks.com
  • Profit from the Pros newsletter
  • About Zacks Equity Research
  • About Zacks
  • http://www.zacks.com/performance
  • http://at.zacks.com/?id=4579
  • http://at.zacks.com/?id=2649
  • http://at.zacks.com/?id=2677
  • http://at.zacks.com/?id=4580